Solicitation-Radiopharmaceuticals -Evans Army Community Hospital
ID: W81K0024Q0167Type: Solicitation
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE ARMYW40M USA HCAJBSA FT SAM HOUSTON, TX, 78234-4504, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/b4188de5707846188523839f573d18fb/view
Timeline
    Description

    The Evans Army Community Hospital in Fort Carson, Colorado, is seeking radiopharmaceuticals through a federal contract. The main purpose of this solicitation, W81K00-24-Q-0167, is to obtain these specialized pharmaceuticals for the hospital's needs.

    Scope of Work

    The successful awardee will be responsible for supplying radiopharmaceuticals as outlined in the attached Statement of Work (SOW). The SOW details the specific requirements and expectations, including the delivery of a comprehensive range of radiopharmaceuticals. Awardees will need to provide pricing information for the products listed in the attached RPH Product List.

    Eligibility Criteria

    Eligible applicants for this opportunity should have expertise and experience in the pharmaceutical industry, specifically in manufacturing and supplying radiopharmaceuticals. The ability to comply with the specific requirements outlined in the SOW and meet the pricing expectations is crucial.

    Funding and Contract Details

    The contract type is not specified in the provided information. However, the notice emphasizes the importance of reviewing the relevant FAR (Federal Acquisition Regulation) addenda for instructions and evaluation criteria. The estimated funding for this contract is not available in the provided information.

    Submission Process

    Offerors are required to submit their questions by email, with a copy to both the primary and secondary contact, by the deadline of 10:00 AM (Mountain) on July 31, 2024. The submissions should refer to the attached documents, specifically the SOW and RPH Product List, when crafting their proposals.

    Evaluation Criteria

    The evaluation of offers will be based on the guidelines outlined in the FAR 52.212-1 and FAR 52.212-2 addenda. The specific evaluation criteria are not provided in the information supplied, but typically include factors such as price, technical merit, and past performance.

    Contact Information

    For any questions or clarifications, offerors should contact the primary contact, Fabiola Palma-Trujillo, via email at fabiola.palma-trujillo.civ@health.mil. Ms. Robyn Villafranco should also be copied on all communications (email: Robyn.A.Villafranco.civ@health.mil).

    Please note that the above summary is based on the information provided and may not cover all the nuances of the opportunity. For a comprehensive understanding, carefully review the attached documents referenced in the opportunity listing.

    Point(s) of Contact
    Fabiola Palma-Trujillo
    fabiola.palma-trujillo.civ@health.mil
    Robyn Villafranco
    Robyn.A.Villafranco.civ@health.mil
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Solicitation-Radiopharmaceuticals -Evans Army Community Hospital
    Currently viewing
    Solicitation
    Similar Opportunities
    6505--Pylarify(Piflufolastat F18 Injection) for DC VAMC
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified sources to provide Pylarify (Piflufolastat F18 Injection) for the DC Veterans Affairs Medical Center (DC VAMC) in Washington, D.C. The procurement involves the delivery of this radiopharmaceutical to the Nuclear Medicine Section of the Radiology Service, with a base contract period of one year and four optional one-year extensions. This product is critical for diagnostic imaging and treatment in nuclear medicine, and the contractor must ensure compliance with various regulatory standards while providing online ordering capabilities and timely deliveries. Interested parties should submit their responses, including company information and capabilities, to Ryan Singletary at Ryan.Singletary@va.gov by September 16, 2024, at 3:00 PM EST.
    6505--Plyarify - Radiopharmaceuticals
    Active
    Veterans Affairs, Department Of
    Special Notice: VETERANS AFFAIRS, DEPARTMENT OF is seeking to procure Plyarify - Radiopharmaceuticals. Plyarify is a radioactive diagnostic agent used for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer. The procurement involves the preparation and delivery of F-18 Piflufolastat (Pylarify) doses performed at a contractor facility and delivered to the PET/CT Service at VA Connecticut Healthcare in West Haven, CT. Deliveries will be made Monday through Friday between 7:00 am and 3:00 pm. Only vendors within a 60-mile radius of VA Connecticut need to respond to this RFQ. The contractor's personnel must be licensed in a State, Territory, or Commonwealth of the United States or the District of Columbia. The contractor will bill on a monthly basis, itemizing all services rendered. The services covered by this contract shall be furnished by the contractor Monday through Friday, 7:00 am - 3:00 pm. There is no restriction on the number of orders or deliveries required per day. The delivery location is VA Connecticut Healthcare System in West Haven, CT. Interested parties must submit their capability to fulfill the requirement in writing by Monday, July 15, 2024, at 12 pm EST time.
    6505--VA GLA Radiopharmaceuticals
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Greater Los Angeles Healthcare System, is soliciting quotes for a five-year Indefinite-Delivery Indefinite-Quantity (IDIQ) contract to supply various radiopharmaceuticals to its Nuclear Medicine Service. The procurement includes essential medical isotopes such as Tc-99m and I-131 Sodium Iodide, which are critical for diagnostic imaging and therapeutic procedures, ensuring that healthcare facilities can maintain adequate stock levels of these vital materials. Interested vendors must comply with federal regulations, provide shipping costs in their quotes, and ensure that all products are sourced from authorized distributors, with responses due by September 11, 2024. For inquiries, potential offerors can contact Contract Specialist Hestia Sim at Hestia.Sim@va.gov.
    Notice of Intent to Sole Source a Blanket Purchase Agreement (BPA) for a variety of radiopharmaceuticals (radiology medications) for use in the Nuclear Medicine Division at Naval Medical Center San Diego
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), intends to award a sole source Blanket Purchase Agreement (BPA) to RLS (USA), Inc. for the procurement of various radiopharmaceuticals required by the Nuclear Medicine Division at Naval Medical Center San Diego (NMCSD). This five-year contract will cover the supply of 31 essential radiopharmaceuticals, four additional medications, and expedited delivery services, all of which are critical for diagnostic imaging and treatment in Nuclear Medicine. Due to the radioactive nature and short shelf-life of these medications, strict adherence to transportation regulations is necessary, with deliveries occurring daily. Interested vendors may submit capability statements by September 10, 2024, to Jennifer Collins at jennifer.e.collins23.civ@health.mil, as this opportunity does not involve competitive proposals.
    6505--Neuraceq - Radiopharmaceuticals
    Active
    Veterans Affairs, Department Of
    Special Notice: VETERANS AFFAIRS, DEPARTMENT OF is seeking a sole source procurement for Neuraceq - Radiopharmaceuticals. Neuraceq is a radioactive diagnostic agent used for Positron Emission Tomography (PET) imaging of the brain. It is used to estimate -amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer's Disease (AD) and other causes of cognitive decline. The procurement involves the preparation and delivery of F-18 Florbetaben (NeuraCeq) doses performed at a contractor facility and delivered to the PET/CT Service at VA Connecticut Healthcare in West Haven, CT. The deliveries will be made Monday through Friday between 7:00 am and 3:00 pm. Only vendors within a 60-mile radius of VA Connecticut need to respond to this RFQ.
    6505 -- SIR Y-90 Resin Microspheres Brand Name or Equal
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking a contractor to provide Yttrium-90 (Y-90) SIR-Spheres resin microspheres for cancer treatment at the VA Palo Alto Healthcare System. This procurement involves a sole source award to Sirtex Medical Inc., with the contract set to span from October 1, 2024, to September 30, 2025, requiring compliance with various regulatory standards for handling radioactive materials. The SIR-Spheres are critical for treating patients with unresectable cancers, ensuring safe and compliant delivery of these specialized medical supplies. Interested vendors may submit a capabilities statement to Derek L. Brown at derek.brown7@va.gov, with all responses considered at the discretion of the government.
    Fluorodeoxyglucose-18
    Active
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is planning to award a sole source contract for Fluorodeoxyglucose-18 (FDG-18) to Hamamatsu-Queen's PET Imaging Center for use at Tripler Army Medical Center in Hawaii. This procurement, which falls under the NAICS code 325412, is intended to support medical readiness and will span from October 1, 2024, through September 30, 2029, including four one-year option periods. FDG-18 is a critical radiopharmaceutical used in positron emission tomography (PET) imaging, essential for various diagnostic procedures. Interested parties may submit capability statements or quotations for consideration, and all inquiries should be directed to Wendi Young-Asao at wendi.t.young-asao.civ@health.mil.
    Teleradiology Services for VASNHCS
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for Teleradiology Services for the Veterans Affairs Southern Nevada Health Care System (VASNHCS). The contract requires certified or board-eligible radiology physicians to provide remote diagnostic imaging services, including CT, MRI, and ultrasound scans, in accordance with strict American College of Radiology standards. This procurement is critical for ensuring timely and accurate diagnostic services for veterans, with an estimated total contract value of $19 million over the performance period from December 1, 2024, to November 30, 2029. Interested vendors should contact Maricela A Berrones-Gauger at maricela.berrones-gauger@va.gov for further details and to submit proposals, adhering to the Service-Disabled Veteran-Owned Small Business (SDVOSB) set-aside requirements.
    Q522--FY25: Tele-Radiology Mammography| WPB
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to provide off-site Tele-Radiology Mammography services for the West Palm Beach VA Medical Center (WPBVAMC) in Florida. The procurement aims to identify certified Service-Disabled Veteran Owned Small Businesses (SDVOSB), Veteran Owned Small Businesses (VOSB), and other small businesses capable of delivering these essential diagnostic imaging services, adhering to the standards set by the American College of Radiology. The anticipated contract period is from November 1, 2024, through October 31, 2029, with four optional one-year extensions, and interested parties must submit their capability statements by September 12, 2024, to the Contracting Officer, Peter Bedard, at peter.bedard@va.gov.
    W91WRZ24Q0014 - RADIOGRAPHIC UNIT (X-Ray unit)
    Active
    Dept Of Defense
    The Department of Defense, through the Regional Contracting Office at Guantanamo Bay, Cuba, is seeking qualified vendors to provide a ceiling-mounted radiographic (X-ray) unit, including its installation and maintenance services. The procurement requires compliance with detailed specifications outlined in the Performance Work Statement (PWS), on-site training for staff within 60 days of contract award, and ongoing maintenance as specified. This X-ray unit is crucial for supporting medical services at the Guantanamo Bay facility, ensuring the availability of essential healthcare technology. Interested vendors must submit their quotes by 5:00 PM on September 9, 2024, and can direct inquiries to primary contact Ericka Collins at ericka.t.collins.mil@mail.mil or secondary contact John Gathu at john.p.gathu.mil@mail.mil.